Relationship of Metabolic Syndrome and Its Components With Thyroid Cancer
- Conditions
- Thyroid Cancer
- Registration Number
- NCT03006289
- Lead Sponsor
- Lin Liao
- Brief Summary
The purpose of this study is to investigate the association between metabolic syndrome (MS), body mass index (BMI), hyperglycemia, dyslipidemia, hypertension and thyroid cancer. Screen for the risk factors that affect the incidence of thyroid cancer.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 3000
Inclusion Criteria
- patients undergone thyroid surgery
- signed the informed consent
Exclusion Criteria
1.patients with no surgery
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method lipids before the thyroid surgery
- Secondary Outcome Measures
Name Time Method glucose before the thyroid surgery
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link metabolic syndrome components to thyroid cancer progression?
How does metabolic syndrome influence the effectiveness of standard thyroid cancer therapies?
Which biomarkers in metabolic syndrome patients predict thyroid cancer risk or treatment response?
What adverse events are associated with metabolic syndrome management in thyroid cancer patients?
Are there combination therapies targeting metabolic syndrome and thyroid cancer pathways currently in development?